Evidence map›Paper›PMID 38240248›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2023

Single-nucleotide polymorphisms of

Jiao Jie, Tengfei Wu

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jiao JieDepartment of Ophthalmology, The Fourth People's Hospital of Shenyang, Shenyang 110031, P.R. China.ORCID 0009-0000-1207-2923
Tengfei WuDepartment of Laboratory Animal Science, China Medical University, Shenyang, Liaoning 110122, P.R. China.
China Medical University · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential for adverse outcomes and classifications of glaucoma differ among race, country, gender, and family medical history. Nearly, 50 represent candidate genes are considered as potential contributors to the happening for the primary open-angle glaucoma (POAG) since the advent of GWASs. Our investigation is the first to report the Toll-like receptor 4 (

Indexed as

Glaucoma, Open-AngleCase-Control StudiesChinaGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansNerve Tissue ProteinsPolymorphism, Single NucleotideToll-Like Receptor 4GAS7 protein, humanNerve Tissue ProteinsTLR4 protein, humanToll-Like Receptor 4ChinesediseaseGAS7haplotypePrimary open-angle glaucomaTLR4

Identifiers

PMID38240248
PMCPMC10903258
OpenAlexW4391036267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.